[{"Assets_0_Q2_USD":"6386223000.0","CIK":"12208","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"8.99","EarningsPerShareBasic_2_Q2_USD":"31.03","EarningsPerShareDiluted_1_Q2_USD":"8.87","EarningsPerShareDiluted_2_Q2_USD":"30.63","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","Market Cap":"16656203893.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"118208000.0","NetIncomeLoss_1_Q2_USD":"268043000.0","NetIncomeLoss_2_Q2_USD":"924817000.0","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","RevenuesConverted_1_Q2_USD":"575911000.0","RevenuesConverted_2_Q2_USD":"1127430000.0","SP500":"SP500","Sector":"Capital Goods","StockholdersEquity_0_Q2_USD":"4638946000.0","Ticker":"BIO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"30219000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"30197000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"29814000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"29801000.0","filed":"20180809","footnote":null,"form":"10-Q","fp":"Q2","fy":"2018.0","name":"BIO-RAD LABORATORIES, INC.","period":"20180630","qtrs":"0","uom":"USD"}]